Reaction
Injection Site Necrosis reporting signals
As of the last recalculation, Injection Site Necrosis appears in 2,021 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is GLATIRAMER ACETATE (PRR 81.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Glatiramer Acetate | 384 | 81.5 | 82.0 |
| Interferon Beta-1B | 134 | 77.0 | 77.6 |
| Naltrexone | 73 | 25.3 | 25.3 |
| Fulvestrant | 54 | 17.3 | 17.3 |
| Cabotegravir | 9 | 11.5 | 11.5 |
| Interferon Beta-1A | 196 | 11.5 | 11.5 |
| Buprenorphine | 98 | 11.4 | 11.4 |
| Methylprednisolone Acetate | 8 | 10.3 | 10.3 |
| Tolterodine Tartrate | 8 | 9.2 | 9.2 |
| Diclofenac Sodium | 94 | 6.7 | 6.7 |
| Rasagiline Mesylate | 6 | 5.6 | 5.6 |
| Lanreotide Acetate | 4 | 5.3 | 5.3 |
| Pegvaliase-Pqpz | 4 | 5.0 | 5.0 |
| Peginterferon Beta-1A | 6 | 4.7 | 4.7 |
| Leuprolide Acetate | 35 | 4.7 | 4.7 |
| Azacitidine | 13 | 4.5 | 4.5 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 10 | 4.3 | 4.3 |